Literature DB >> 7001265

Blood-brain barrier: a definition of normal and altered function.

M Pollay, P A Roberts.   

Abstract

The anatomical component of the blood-brain barrier (BBB) has been shown to be the cerebral capillary. These capillary endothelial cells are connected by continuous tight intercellular junctions and under normal conditions do not demonstrate transendothelial channels or pinocytotic vesicles. The rate that substances penetrate the BBB is related to molecular size, lipid solubility, and the presence of a specific carrier-mediated transport system. This latter mechanism for transendothelial passage is utilized for the movement of a wide variety of biologically important compounds such as sugars, amino acids, and organic acids. In certain pathological conditions, the permeability of the BBB is altered so that normally excluded plasma proteins and fluid enter the brain extracellular space, with the subsequent development of cerebral edema. In other abnormal conditions, alterations in the specialized transport systems operating across the cerebral capillary result in adverse changes in cerebral and neurotransmitter metabolism. An understanding of the unique properties of the BBB and of the changes that occur in pathological conditions has allowed the development of rational therapeutic strategies for a wide variety of diseases of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001265     DOI: 10.1227/00006123-198006000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Harvesting blood stem cells from cranial bone at craniotomy--a preliminary study.

Authors:  Tomomi Iwashita; Tsuyoshi Tada; Hua Zhan; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

2.  Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.

Authors:  J A Williams; L E Dillehay; K Tabassi; E Sipos; C Fahlman; H Brem
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 3.  Embracing rejection: Immunologic trends in brain metastasis.

Authors:  S Harrison Farber; Vadim Tsvankin; Jessica L Narloch; Grace J Kim; April K S Salama; Gordana Vlahovic; Kimberly L Blackwell; John P Kirkpatrick; Peter E Fecci
Journal:  Oncoimmunology       Date:  2016-04-11       Impact factor: 8.110

4.  Preparation of laminin/nidogen adsorbed urinary bladder decellularized materials via a mussel-inspired polydopamine coating for pelvic reconstruction.

Authors:  Liangpeng Ge; Chuan Cao; Shixuan Chen; Bin Shao; Qianyong Li; Qingtao Li; Lubin Liu; Zhiqing Liang; Yong Huang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 5.  The relationship of intracranial venous pressure to hydrocephalus.

Authors:  H D Portnoy; C Branch; M E Castro
Journal:  Childs Nerv Syst       Date:  1994-01       Impact factor: 1.475

6.  Heat stress affects blood-brain barrier permeability to horseradish peroxidase in mice.

Authors:  J A Wijsman; R R Shivers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets.

Authors:  B Rama; T Mandel; J Jansen; E Dingeldein; H D Mennel
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

8.  The blood-brain barrier and response of C.N.S. metastases to chemotherapy.

Authors:  G C Toner; J Pike; M A Schwarz
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

9.  Continuous monitoring of the Monro-Kellie doctrine: is it possible?

Authors:  Dong-Joo Kim; Zofia Czosnyka; Magdalena Kasprowicz; Piotr Smieleweski; Oliver Baledent; Anne-Marie Guerguerian; John D Pickard; Marek Czosnyka
Journal:  J Neurotrauma       Date:  2011-11-04       Impact factor: 5.269

Review 10.  Classification of the cerebral edemas with reference to hydrocephalus and pseudotumor cerebri.

Authors:  T H Milhorat
Journal:  Childs Nerv Syst       Date:  1992-09       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.